Trinity Biotech PLC

Trinity Biotech PLC, through its subsidiaries including Biopool U.S., Inc. and Trinity Biotech Distribution, is a leading provider of clinical laboratory diagnostic products and services to the U.S. federal government. Headquartered in Ireland, Trinity Biotech specializes in the development, manufacture, and marketing of diagnostic test kits and instruments for point-of-care and clinical laboratory use. The company's product portfolio includes tests for infectious diseases, autoimmune disorders, and hemoglobin disorders. Trinity Biotech has established a strong presence in the U.S. government contracting space, supplying critical medical testing products and equipment to various federal agencies.

Through its federal contract awards, Trinity Biotech has provided a wide range of diagnostic products and services to government agencies. These include hemoglobin A1c analyzers, syphilis and HIV test kits, G-6-PDH screening test kits, and associated reagents and controls. The company has received numerous delivery orders from the Defense Logistics Agency Troop Support Medical for laboratory supplies, including SYPH G EIA 1-plate tests and G-6-PDH screening kits. Trinity Biotech has also secured contracts with the Department of Veterans Affairs to provide hemoglobin A1c testing services on a cost per reportable result basis, as well as glycated hemoglobin testing equipment and supplies. Other clients include the Department of Justice's Bureau of Prisons and the National Institutes of Health. Many of these awards have been made without set-aside designations, although some contracts with the VA have utilized small business set-asides.

Trinity Biotech holds several significant federal contract IDVs. The company was awarded a $100 million single-award Blanket Purchase Agreement by the National Institutes of Health for the provision of blood products, media, biological materials, and medical/scientific equipment. A $199,500 BPA was awarded by the Department of Justice for hemoglobin A1c analyzers and related services. The Department of Veterans Affairs granted a $170,000 BPA for hemoglobin A1c testing services. Additionally, Trinity Biotech secured a $4 million Indefinite Delivery Contract from the Defense Logistics Agency for laboratory supplies ordered through the DLA Electronic Catalog. These IDVs enable various federal agencies to efficiently procure Trinity Biotech's diagnostic products and services, supporting critical healthcare and research initiatives across the government.